BioCentury | Jun 24, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...treat cancer. SciBX 3(25); doi:10.1038/scibx.2010.758 Published online June 24, 2010 Patent and licensing status undisclosed Carrington...
BioCentury | Aug 4, 2008
Company News

DelSite, Medline Industries Inc. deal

...sell its Carrington wound care division to Medline for an undisclosed sum. Medline already markets Carrington’s...
BioCentury | May 26, 2008
Company News

Carrington, National Institutes of Health deal

...vaccine with DelSite’s GelSite delivery polymer. Terms were not disclosed (see BioCentury, May 21, 2007). Carrington Laboratories Inc....
BioCentury | Jan 21, 2008
Clinical News

GelVac avian H5N1 influenza vaccine: Phase I start

...This year, Carrington’s DelSite Biotechnologies Inc. unit will begin a dose-escalation, U.S. Phase I trial in...
...DelSite Biotechnologies Inc. unit will begin a dose-escalation, U.S. Phase I trial in healthy volunteers. Carrington Laboratories Inc....
BioCentury | Jan 21, 2008
Clinical News

Carrington preclinical data

...In rabbit and rat models of bird flu, Carrington's avian H5N1 influenza vaccine was safe and...
...vaccine delivered using the GelVac nasal powder delivery system is expected to begin this year. Carrington Laboratories Inc....
BioCentury | Dec 10, 2007
Company News

Carrington, ImmuneRegen deal

...P, is in preclinical testing for multiple indications, including influenza. Financial details were not disclosed. Carrington Laboratories Inc....
BioCentury | Oct 1, 2007
Company News

Carrington, ElSohly Laboratories Inc. deal

...delivery technology. ElSohly is developing compounds to treat cancer and performs drug abuse testing services. Carrington Laboratories Inc....
BioCentury | Aug 20, 2007
Clinical News

GelVac avian H5N1 influenza vaccine: Phase I start

...In 1Q08, CARN hopes to begin a Phase I trial in about 75 patients. Carrington Laboratories Inc. (CARN...
BioCentury | Jul 30, 2007
Company News

Brookwood Pharmaceuticals Inc., Carrington deal

...deliver proteins and peptides (see BioCentury, Feb. 28, 2005). Brookwood Pharmaceuticals Inc. , Birmingham, Ala. Carrington Laboratories Inc....
BioCentury | Jun 25, 2007
Company News

Carrington board of directors update

Carrington Laboratories Inc. (CARN), Irving, Texas Business: Dermatology, Infectious, Drug delivery Appointed: Alex McPherson, former president and CEO of Biomira Inc. WIR Staff...
Items per page:
1 - 10 of 81
BioCentury | Jun 24, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...treat cancer. SciBX 3(25); doi:10.1038/scibx.2010.758 Published online June 24, 2010 Patent and licensing status undisclosed Carrington...
BioCentury | Aug 4, 2008
Company News

DelSite, Medline Industries Inc. deal

...sell its Carrington wound care division to Medline for an undisclosed sum. Medline already markets Carrington’s...
BioCentury | May 26, 2008
Company News

Carrington, National Institutes of Health deal

...vaccine with DelSite’s GelSite delivery polymer. Terms were not disclosed (see BioCentury, May 21, 2007). Carrington Laboratories Inc....
BioCentury | Jan 21, 2008
Clinical News

GelVac avian H5N1 influenza vaccine: Phase I start

...This year, Carrington’s DelSite Biotechnologies Inc. unit will begin a dose-escalation, U.S. Phase I trial in...
...DelSite Biotechnologies Inc. unit will begin a dose-escalation, U.S. Phase I trial in healthy volunteers. Carrington Laboratories Inc....
BioCentury | Jan 21, 2008
Clinical News

Carrington preclinical data

...In rabbit and rat models of bird flu, Carrington's avian H5N1 influenza vaccine was safe and...
...vaccine delivered using the GelVac nasal powder delivery system is expected to begin this year. Carrington Laboratories Inc....
BioCentury | Dec 10, 2007
Company News

Carrington, ImmuneRegen deal

...P, is in preclinical testing for multiple indications, including influenza. Financial details were not disclosed. Carrington Laboratories Inc....
BioCentury | Oct 1, 2007
Company News

Carrington, ElSohly Laboratories Inc. deal

...delivery technology. ElSohly is developing compounds to treat cancer and performs drug abuse testing services. Carrington Laboratories Inc....
BioCentury | Aug 20, 2007
Clinical News

GelVac avian H5N1 influenza vaccine: Phase I start

...In 1Q08, CARN hopes to begin a Phase I trial in about 75 patients. Carrington Laboratories Inc. (CARN...
BioCentury | Jul 30, 2007
Company News

Brookwood Pharmaceuticals Inc., Carrington deal

...deliver proteins and peptides (see BioCentury, Feb. 28, 2005). Brookwood Pharmaceuticals Inc. , Birmingham, Ala. Carrington Laboratories Inc....
BioCentury | Jun 25, 2007
Company News

Carrington board of directors update

Carrington Laboratories Inc. (CARN), Irving, Texas Business: Dermatology, Infectious, Drug delivery Appointed: Alex McPherson, former president and CEO of Biomira Inc. WIR Staff...
Items per page:
1 - 10 of 81